Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain
Clinical trial NCT03585270 · COMPLETED
Trial details
- NCT number
- NCT03585270
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-03
- Primary completion
- 2022-06-13
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.